Ibi bibaye nyuma yuko Kabila asubiye muri DRC mu kwezi gushize, mu gihe ubushyamirane bwiyongereye hagati ye na leta itegekwa n'uwamusimbuye, Perezida Félix Tshisekedi. Abategetsi barimo guharanira ko ...

As fantasy readers, we're drawn to books with stories that not only transport us to faraway realms but also crack open truths ...

Eyi ni ohun to sẹlẹ ni ile ẹjọ lonii lẹyin ti igbẹjọ naa bẹrẹ laago mẹsan kọja isẹju mẹfa ni ile ẹjọ giga ipinlẹ kwara labẹ ...

Updated data on IBI363 monotherapy in patients with advanced NSCLC were reported (ClinicalTrials.gov, NCT05460767). As of the ...

New phase 1 findings highlight promise of first-in-class bispecific antibody fusion for advanced colorectal cancer.

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

Top Ships ( ($TOPS) ) has provided an announcement. On June 4, 2025, TOP Ships Inc. announced its intention to spin off two Suezmax tanker vessels ...

Most Read from BloombergNY Private School Pleads for Donors to Stay Open After Declaring BankruptcyUAE’s AI University Aims ...

Climate change has swallowed beaches in the Barcelona municipality, which has lost €1 million a year since the pandemic due ...

IBI354 has demonstrated promising anti-tumor efficacy and favorable safety profiles across multiple solid tumors. It not only holds potential to deliver a new generation of ADC therapies characterized ...

In terms of safety, among participants receiving monotherapy and combination therapy, 19 (27.9%) and 26 (35.6%) reported treatment-related adverse events (TRAEs) of Grade 3 or higher ...

The Wall That Heals 2025 Committee is launching efforts to honor Vietnam War veterans and commemorate military personnel ...